Commentary – Omega-3 fatty acids and cardiovascular disease: do placebo doses give placebo results?

A Science Advisory from the American Heart Association (AHA) was recently published providing a relatively tepid endorsement on the use of omega-3 supplements for secondary prevention of myocardial infarction and existing heart failure, but did not recommend their use for primary prevention in patients with diabetes or pre-diabetes, patients with high cardiovascular disease risk, recurrent … Continue reading Commentary – Omega-3 fatty acids and cardiovascular disease: do placebo doses give placebo results?